Salagen (pilocarpine)
An approved treatment for Sjögren's Syndrome.
Drug facts
The same compound appears under different names depending on the context. Here is how to identify Pilocarpine wherever you encounter it, plus the key facts at a glance.
- Generic name
- Pilocarpine
- Brand name
- Salagen
- Drug class
- Parasympathomimetic (muscarinic agonist)
- Manufacturer
- Advanz Pharma (Salagen); generics from multiple makers
- How it's taken
- Taken as a 5mg oral tablet, 3 to 4 times daily.
An oral medication that stimulates saliva and tear production by activating muscarinic receptors on exocrine glands.
Pilocarpine treats the dryness symptoms of Sjögren's syndrome but does not modify the underlying autoimmune disease process.
We'll email you when Salagen's FDA label changes, when the FDA acts on it, and when new trials for Sjögren's Syndrome open. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
We never share your email. Unsubscribe anytime. Privacy policy · Check any health site
Where Pilocarpine fits
One of 2 FDA-approved oral secretagogues for Sjögren's dry mouth symptoms (along with cevimeline).
- Treats symptoms only; does not modify the underlying autoimmune disease.
- Often used in combination with artificial tears, saliva substitutes, and dental care.
- Disease-modifying therapies like ianalumab are in development but not yet available.
How Pilocarpine works
Sjögren's syndrome destroys the salivary and tear glands through autoimmune inflammation, leaving patients with severe dryness of the mouth and eyes. While the glands are damaged, many patients still have some residual gland tissue that can be stimulated to produce moisture.
Pilocarpine activates muscarinic receptors (specifically M3 receptors) on the remaining glandular cells, telling them to secrete saliva and tears. It essentially turns up the output of whatever gland tissue remains functional. This can significantly improve mouth moisture, reduce dental decay risk, and ease the difficulty swallowing and speaking that plagues many Sjögren's patients.
Pilocarpine is purely symptomatic: it helps manage dryness but does not slow the autoimmune attack on the glands. The effect lasts only while the drug is being taken, and it works best in patients who still have some residual gland function.
Side effects and safety
The most common side effect is sweating (affecting up to 40% of patients), which occurs because pilocarpine stimulates sweat glands along with salivary and tear glands. Other common effects include nausea, chills, flushing, increased urinary frequency, dizziness, and watery eyes. Most side effects are dose-related and can be managed by starting at a lower dose and gradually increasing.
Pilocarpine should not be used in patients with uncontrolled asthma or narrow-angle glaucoma. The label also warns about use in people with significant heart disease or with controlled asthma, chronic bronchitis or COPD, and about blurred vision that can make night driving unsafe; it should be used with caution by people with gallbladder disease or kidney stones.
This is not a complete list of side effects. Talk to your doctor or pharmacist about what to expect and when to seek medical attention.
Taking Pilocarpine
Taken as a 5mg oral tablet, 3 to 4 times daily. The dose may be adjusted based on response and tolerability. Effects typically begin within 30 minutes and last 3-5 hours. Should be taken with a full glass of water.
Availability and cost
Generic versions may be available at a lower cost. Ask your pharmacist.
Help paying for Salagen
Several companies make generic pilocarpine, so no single drugmaker program covers every version. Drugmaker copay cards can't be used with Medicare, Medicaid or TRICARE. Pick your insurance below to see which offers fit you.
No drugmaker assistance program for this medicine is published on the maker's official pages.
Good to know: Pilocarpine tablets are sold as generics by many manufacturers; there is no single drugmaker assistance program. Ask your pharmacist about lower-cost generic options.
Pilocarpine treatment timeline for Sjögren's Syndrome
Tap how long you have been on Pilocarpine to drop your pin on the road. Your answers stay on this device.
Stage 1 of 5 · Start to 1 mo
Starting pilocarpine
You are starting pilocarpine (Salagen) for dry mouth caused by Sjögren's syndrome. Pilocarpine is a muscarinic receptor agonist that stimulates your remaining salivary gland tissue to produce more saliva. It also stimulates tear glands and, unfortunately, sweat glands. For Sjögren's, the label dose is 5mg four times a day. Your doctor may adjust this if you have liver problems. The key thing to understand about pilocarpine is that it treats symptoms but does not slow or stop the autoimmune process attacking your glands. It works by squeezing more output from the glandular tissue you still have, so how much it helps can depend on how much working gland tissue remains. Sweating is the most common side effect. It affected about 40% of people with Sjögren's taking 5mg four times daily in studies. The label notes that a high-fat meal slows how fast pilocarpine is absorbed, so ask your doctor how to time doses around meals.
Coming up
Some people notice more saliva within an hour of a dose. In the Sjögren's studies, benefit was measured at 6 weeks. In the label's Sjögren's studies, sweating was the most common reason people stopped treatment, so tell your doctor if it bothers you. The label's Sjögren's dose is 5mg four times a day, and it gives no higher dose for Sjögren's. If relief is not enough or sweating is hard to live with, ask your doctor about the options. One option is cevimeline (Evoxac), a similar medicine approved for Sjögren's dry mouth.
Get in touch with your rheumatologist if you notice
- Difficulty breathing, wheezing, or chest tightness: get medical help right away (pilocarpine can tighten the airways and should not be used with uncontrolled asthma)
- Visual disturbances or eye pain (pilocarpine affects pupil size and can worsen narrow-angle glaucoma)
- Severe sweating causing dehydration (dizziness, dark urine, rapid heart rate)
- Nausea or vomiting severe enough that you cannot keep taking the medication
- Allergic reaction: hives, facial swelling, difficulty breathing
- Should I start at a lower dose and work up to reduce side effects?
- Is it better to take pilocarpine before meals, during meals, or after?
- What can I do about the sweating: will it get better over time?
- Will pilocarpine also help my dry eyes, or do I need separate treatment for that?
- How much gland tissue do I have left? Will pilocarpine be effective at my stage of disease?
- Should I also be using artificial saliva or other dental products alongside pilocarpine?
Every stage of Pilocarpine treatment at a glance
Starting pilocarpine Start to 1 mo
You are starting pilocarpine (Salagen) for dry mouth caused by Sjögren's syndrome. Pilocarpine is a muscarinic receptor agonist that stimulates your remaining salivary gland tissue to produce more saliva. It also stimulates tear glands and, unfortunately, sweat glands. For Sjögren's, the label dose is 5mg four times a day. Your doctor may adjust this if you have liver problems. The key thing to understand about pilocarpine is that it treats symptoms but does not slow or stop the autoimmune process attacking your glands. It works by squeezing more output from the glandular tissue you still have, so how much it helps can depend on how much working gland tissue remains. Sweating is the most common side effect. It affected about 40% of people with Sjögren's taking 5mg four times daily in studies. The label notes that a high-fat meal slows how fast pilocarpine is absorbed, so ask your doctor how to time doses around meals.
Some people notice more saliva within an hour of a dose. In the Sjögren's studies, benefit was measured at 6 weeks. In the label's Sjögren's studies, sweating was the most common reason people stopped treatment, so tell your doctor if it bothers you. The label's Sjögren's dose is 5mg four times a day, and it gives no higher dose for Sjögren's. If relief is not enough or sweating is hard to live with, ask your doctor about the options. One option is cevimeline (Evoxac), a similar medicine approved for Sjögren's dry mouth.
Dose optimization 1 mo to 3 mo
You have been on pilocarpine for 1-3 months and you and your doctor are seeing how well it works. By now, you have a sense of whether the drug is increasing your saliva production and how well you tolerate the side effects. The sweating may have improved since the first few weeks, or it may still be bothersome. If the standard 5mg four times daily dose is working, you have likely settled into a routine. If the response is not enough, your doctor may talk with you about other options. Some people time their doses around meals, within the schedule their doctor has set. Others take it at evenly spaced times for steady saliva production.
If pilocarpine is helping and the side effects are manageable, your doctor may suggest staying on it. Your doctor may recommend a dental visit to assess the impact on your oral health, since improving saliva production can help protect against the rampant dental decay that affects many Sjögren's patients. If pilocarpine is not providing enough relief, the options include: switching to cevimeline, or adding complementary measures (prescription fluoride, saliva substitutes, humidifiers). If your dry eyes are not adequately addressed by pilocarpine's secondary effect on tear glands, your ophthalmologist may recommend additional treatments like cyclosporine eye drops (Restasis) or lifitegrast (Xiidra).
Assessing the response 3 mo to 6 mo
By 3-6 months, you and your doctor have a clear picture of how much pilocarpine is helping your dry mouth. In clinical trials, pilocarpine significantly improved salivary flow rate and patient-reported dryness compared to placebo. However, the degree of benefit varies based on how much functional gland tissue remains. If your glands are severely damaged, pilocarpine may provide modest improvement at best because there is less tissue to stimulate. Your doctor is evaluating whether pilocarpine alone is providing adequate symptom control or whether additional measures are needed. This is also a good time to check in on the broader Sjögren's picture: are your systemic symptoms (fatigue, joint pain, brain fog) being managed, is your dental health stable, and are your eyes adequately treated?
For people with good symptom control, doctors usually reassess from time to time. Dental visits every 3-4 months (more frequent than the general population) are recommended for Sjögren's patients. Your rheumatologist will continue monitoring for systemic disease activity and lymphoma risk factors (persistent parotid swelling, low C4 complement, monoclonal gammopathy), since Sjögren's raises lymphoma risk compared with the general population, though most people with Sjögren's never develop lymphoma. For patients with partial relief: combination strategies are worth discussing. Using pilocarpine for meals and social situations while relying on saliva substitutes in between doses is a common practical approach. The label says medicines that act like pilocarpine, such as cevimeline, are expected to add to its effects when taken together, so ask your doctor before combining them. For patients with minimal benefit: the underlying glandular damage may be too advanced for secretagogues to help much. Your doctor should discuss supportive measures, clinical trials of disease-modifying therapies, and focus on dental and eye preservation strategies.
Maintenance treatment 6 mo to 2 yr
You have been on pilocarpine for 6 months to 2 years and it is part of your daily routine. Your Sjögren's management likely involves multiple components beyond pilocarpine: dental care, dry eye treatment, management of fatigue and joint symptoms, and monitoring for systemic complications. The label's studies lasted 12 weeks, so ask your doctor how well it keeps working for you over time. However, Sjögren's is a progressive disease, and glandular function may gradually decline over the years despite symptom management.
Pilocarpine is one part of a wider Sjögren's care plan. Your rheumatologist should be monitoring for systemic complications: annual blood work including complete blood count, kidney function, liver function, and immunoglobulins. Screening for lymphoma risk factors (persistent parotid swelling, certain lab markers like low C4 complement, monoclonal gammopathy, or high beta-2 microglobulin) should be ongoing. Dental care continues at frequent intervals. If a disease-modifying therapy becomes available (several are in late-stage trials), your doctor will discuss whether adding it to your regimen could slow glandular damage and preserve function beyond what pilocarpine alone can maintain.
Long-term management 2 yr on
You have been on pilocarpine for 2 years or more. At this point, pilocarpine is a well-established part of your Sjögren's management. You know your optimal dose, when to take it, and how to manage the side effects. The Sjögren's disease itself may have evolved: some patients stabilize, while others experience gradual progression with declining glandular function. Your comprehensive care team likely includes your rheumatologist, dentist, and ophthalmologist, with additional specialists as needed for specific organ involvement.
Long-term Sjögren's management focuses on preserving function, preventing complications, and maintaining quality of life. Pilocarpine continues as long as it provides benefit. If your dry mouth has worsened over the years despite consistent treatment, it may indicate progressive gland damage. In this scenario, maximizing supportive measures becomes even more important. Several medicines that target the immune process in Sjögren's are in late-stage trials or under FDA review. None is FDA approved for Sjögren's yet. Stay informed through your rheumatologist and patient organizations like the Sjögren's Foundation.
This timeline shows typical patterns from the prescribing information, guidelines and published studies. Your own treatment may differ, and your rheumatologist is the source of truth for your plan. Last checked against the FDA label on .
Clinical trial results
Multiple placebo-controlled trials in the 1990s demonstrated that pilocarpine significantly increased salivary flow rate and improved patient-reported dryness symptoms compared to placebo. These trials supported FDA approval for both radiation-induced dry mouth (1994) and Sjögren's syndrome dry mouth symptoms.
Development history
Pilocarpine has been used in medicine since the 19th century, originally as an eye drop for glaucoma. The oral formulation was developed for xerostomia (dry mouth) and received FDA approval for radiation-induced dry mouth in 1994 and for Sjögren's syndrome dry mouth in 1998. It remains one of only 2 FDA-approved oral secretagogues for Sjögren's dry mouth (alongside cevimeline).
Explore Sjögren's Syndrome trials
Other Sjögren's Syndrome treatments
Common questions about Pilocarpine
▸What is Pilocarpine (Salagen)?
An oral medication that stimulates saliva and tear production by activating muscarinic receptors on exocrine glands. Pilocarpine treats the dryness symptoms of Sjögren's syndrome but does not modify the underlying autoimmune disease process.
▸How does Pilocarpine work?
Sjögren's syndrome destroys the salivary and tear glands through autoimmune inflammation, leaving patients with severe dryness of the mouth and eyes. While the glands are damaged, many patients still have some residual gland tissue that can be stimulated to produce moisture.
Pilocarpine activates muscarinic receptors (specifically M3 receptors) on the remaining glandular cells, telling them to secrete saliva and tears. It essentially turns up the output of whatever gland tissue remains functional. This can significantly improve mouth moisture, reduce dental decay risk, and ease the difficulty swallowing and speaking that plagues many Sjögren's patients.
Pilocarpine is purely symptomatic: it helps manage dryness but does not slow the autoimmune attack on the glands. The effect lasts only while the drug is being taken, and it works best in patients who still have some residual gland function.
▸What are the side effects of Pilocarpine?
The most common side effect is sweating (affecting up to 40% of patients), which occurs because pilocarpine stimulates sweat glands along with salivary and tear glands. Other common effects include nausea, chills, flushing, increased urinary frequency, dizziness, and watery eyes. Most side effects are dose-related and can be managed by starting at a lower dose and gradually increasing. Pilocarpine should not be used in patients with uncontrolled asthma or narrow-angle glaucoma. The label also warns about use in people with significant heart disease or with controlled asthma, chronic bronchitis or COPD, and about blurred vision that can make night driving unsafe; it should be used with caution by people with gallbladder disease or kidney stones.
▸How is Pilocarpine taken?
Taken as a 5mg oral tablet, 3 to 4 times daily. The dose may be adjusted based on response and tolerability. Effects typically begin within 30 minutes and last 3-5 hours. Should be taken with a full glass of water.
▸Is Pilocarpine FDA approved?
Yes, Pilocarpine (Salagen) is FDA approved (1994) for the treatment of Sjögren's Syndrome.
▸Does pilocarpine help with Sjogren's dry mouth?
▸What is the most common side effect of pilocarpine?
Sweating is the most common side effect of pilocarpine, affecting up to 40% of patients. This occurs because pilocarpine stimulates sweat glands along with salivary glands. Starting at a lower dose and gradually increasing can help manage this. [1]
▸How is pilocarpine taken for Sjogren's syndrome?
Pilocarpine is taken as a 5mg oral tablet 3 to 4 times daily with a full glass of water, and the dose may be adjusted based on response and tolerability. Effects typically begin within 30 minutes and last 3 to 5 hours. It should not be used by people with uncontrolled asthma or narrow-angle glaucoma. [1]
▸Is pilocarpine FDA approved for Sjogren's syndrome?
Yes. Oral pilocarpine was FDA-approved for radiation-induced dry mouth in 1994 and for Sjogren's syndrome dry mouth in 1998, based on placebo-controlled trials in the 1990s showing increased salivary flow and improved dryness symptoms. It is one of only 2 FDA-approved oral secretagogues for Sjogren's dry mouth, alongside cevimeline. [1][2]
Sources and references
Every factual claim on this page is drawn from the public sources listed below. Click any reference to open the original document.
- U.S. Food and Drug Administration. SALAGEN (pilocarpine HCl) Tablets Label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020237se8-004_salagen_lbl.pdf
- Archives of Internal Medicine · 1999-01-25. Vivino FB, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. https://pubmed.ncbi.nlm.nih.gov/9927101/